Adult heart transplant: Indications and outcomes

Journal of Thoracic Disease

Volumn 6, Issue 8, 2014, Pages 1120-1128

  Alraies, M Chadi ^a   Eckman, Peter ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Heart transplant; Indications; Outcomes

Indexed keywords

ADULT; ARTICLE; ASSISTED CIRCULATION; CARDIAC ALLOGRAFT VASCULOPATHY; CONGESTIVE HEART FAILURE; DISEASE CLASSIFICATION; DYSPNEA; EXERCISE TEST; HEART GRAFT; HEART TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; PATIENT SELECTION; QUALITY OF LIFE; SCORING SYSTEM; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 84907013399     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.3978/j.issn.2072-1439.2014.06.44     Document Type: Article

References (52)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics 2011 update: A report from the american heart association. Circulation 2011;123:e18-e209.
2. Metra M, Ponikowski P, Dickstein K, et al. Advanced chronic heart failure: A position statement from the study group on advanced heart failure of the heart failure association of the european society of cardiology. Eur J Heart Fail 2007;9:684-94.
3. 2009 annual report of the U.S. organ procurement and transplantation network and the scientific registry of transplant recipients: Transplant data 1999-2008. U.S. department of health and human services, health resources and services administration, healthcare systems bureau, division of transplantation, rockville, MD. Available online: http://www.ustransplant.org/annual_reports/current/. Accessed February 1, 2014.
4. Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: A report of the american college of cardiology foundation/american heart association task force on practice guidelines: Developed in collaboration with the international society for heart and lung transplantation. Circulation 2009;119:e391-479.
5. Butler J, Khadim G, Paul KM, et al. Selection of patients for heart transplantation in the current era of heart failure therapy. J Am Coll Cardiol 2004;43:787-93.
6. Lietz K, Miller LW. Improved survival of patients with end-stage heart failure listed for heart transplantation: Analysis of organ procurement and transplantation network/U.S. united network of organ sharing data, 1990 to 2005. J Am Coll Cardiol 2007;50:1282-90.
7. Stehlik J, Edwards LB, Kucheryavaya AY, et al. The registry of the international society for heart and lung transplantation: Twenty-eighth adult heart transplant report--2011. J Heart Lung Transplant 2011;30:1078-94.
8. Starling RC. Advanced heart failure: Transplantation, LVADs, and beyond. Cleve Clin J Med 2013;80:33-40.
9. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: A report of the american college of cardiology foundation/american heart association task force on practice guidelines. J Am Coll Cardiol 2013;62:e147-239.
10. Jessup M, Brozena S. Heart failure. N Engl J Med 2003;348:2007-18.
11. Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: A report of the american college of cardiology foundation/american heart association task force on practice guidelines: Developed in collaboration with the international society for heart and lung transplantation. Circulation 2009;119:1977-2016.
12. Russo MJ, Rana A, Chen JM, et al. Pretransplantation patient characteristics and survival following combined heart and kidney transplantation: An analysis of the united network for organ sharing database. Arch Surg 2009;144:241-6.
13. Shah MR, Starling RC, Schwartz Longacre L, et al. Heart transplantation research in the next decade--a goal to achieving evidence-based outcomes: National heart, lung, and blood institute working group. J Am Coll Cardiol 2012;59:1263-9.
14. Mehra MR, Kobashigawa J, Starling R, et al. Listing criteria for heart transplantation: International society for heart and lung transplantation guidelines for the care of cardiac transplant candidates--2006. J Heart Lung Transplant 2006;25:1024-42.
15. Starling RC. Improved quantity and quality of life: A winning combination to treat advanced heart failure. J Am Coll Cardiol 2010;55:1835-6.
16. Russo MJ, Chen JM, Hong KN, et al. Survival after heart transplantation is not diminished among recipients with uncomplicated diabetes mellitus: An analysis of the united network of organ sharing database. Circulation 2006;114:2280-7.
17. Taylor DO, Stehlik J, Edwards LB, et al. Registry of the international society for heart and lung transplantation: Twenty-sixth official adult heart transplant report-2009. J Heart Lung Transplant 2009;28:1007-22.
18. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the european society of cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC. Eur J Heart Fail 2012;14:803-69.
19. Mancini DM, Eisen H, Kussmaul W, et al. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991;83:778-86.
20. Goda A, Lund LH, Mancini D. The heart failure survival score outperforms the peak oxygen consumption for heart transplantation selection in the era of device therapy. J Heart Lung Transplant 2011;30:315-25.
21. O'Neill JO, Young JB, Pothier CE, et al. Peak oxygen consumption as a predictor of death in patients with heart failure receiving beta-blockers. Circulation 2005;111:2313-8.
22. Bard RL, Gillespie BW, Lange DC, et al. Improving prognostic assessment of patients with advanced heart failure using ventilatory efficiency. J Heart Lung Transplant 2010;29:589-91.
23. Ferreira AM, Tabet JY, Frankenstein L, et al. Ventilatory efficiency and the selection of patients for heart transplantation. Circ Heart Fail 2010;3:378-86.
24. Chase PJ, Kenjale A, Cahalin LP, et al. Effects of respiratory exchange ratio on the prognostic value of peak oxygen consumption and ventilatory efficiency in patients with systolic heart failure. JACC Heart Fail 2013;1:427-32.
25. Chase P, Arena R, Myers J, et al. Relation of the prognostic value of ventilatory efficiency to body mass index in patients with heart failure. Am J Cardiol 2008;101:348-52.
26. Aaronson KD, Schwartz JS, Chen TM, et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997;95:2660-7.
27. Levy WC, Mozaffarian D, Linker DT, et al. The seattle heart failure model: Prediction of survival in heart failure. Circulation 2006;113:1424-33.
28. Mozaffarian D, Anker SD, Anand I, et al. Prediction of mode of death in heart failure: The seattle heart failure model. Circulation 2007;116:392-8.
29. Gorodeski EZ, Chu EC, Chow CH, et al. Application of the seattle heart failure model in ambulatory patients presented to an advanced heart failure therapeutics committee. Circ Heart Fail 2010;3:706-14.
30. Kalogeropoulos AP, Georgiopoulou VV, Giamouzis G, et al. Utility of the seattle heart failure model in patients with advanced heart failure. J Am Coll Cardiol 2009;53:334-42.
31. Kilic A, Allen JG, Weiss ES. Validation of the united states-derived index for mortality prediction after cardiac transplantation (IMPACT) using international registry data. J Heart Lung Transplant 2013;32:492-8.
32. Smits JM, de Vries E, De Pauw M, et al. Is it time for a cardiac allocation score? first results from the eurotransplant pilot study on a survival benefit-based heart allocation. J Heart Lung Transplant 2013;32:873-80.
33. Mancini D, Lietz K. Selection of cardiac transplantation candidates in 2010. Circulation 2010;122:173-83.
34. Eckman PM. Immunosuppression in the sensitized heart transplant recipient. Curr Opin Organ Transplant 2010;15:650-6.
35. Eckman PM, Hanna M, Taylor DO, et al. Management of the sensitized adult heart transplant candidate. Clin Transplant 2010;24:726-34.
36. Organ procurement and transplantation network (OPTN). Organ distribution: Allocation of hearts and heart-lungs. Department of health and human services, health resources and services administration, healthcare systems bureau, division of transplantation. Available online: http://optn. transplant.hrsa.gov/policiesAndBylaws/policies.asp
37. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001;345:1435-43.
38. Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007;357:885-96.
39. Rosenbaum AN, John R, Liao KK, et al. Survival in elderly patients supported with continuous flow LVAD as bridge to transplant or destination therapy. J Card Fail 2014;20:161-7.
40. Lund LH, Edwards LB, Kucheryavaya AY, et al. The registry of the international society for heart and lung transplantation: Thirtieth official adult heart transplant report--2013; focus theme: Age. J Heart Lung Transplant 2013;32:951-64.
41. Wozniak CJ, Stehlik J, Baird BC, et al. Ventricular assist devices or inotropic agents in status 1A patients? Survival analysis of the United Network of Organ Sharing database. Ann Thorac Surg 2014;97:1364-71; discussion 1371-2.
42. Moazami N, Sun B, Feldman D. Stable patients on left ventricular assist device support have a disproportionate advantage: time to re-evaluate the current UNOS policy. J Heart Lung Transplant 2011;30:971-4.
43. Kamdar F, John R, Eckman P, et al. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices. J Thorac Cardiovasc Surg 2013;145:575-81.
44. John R, Pagani FD, Naka Y, et al. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables. J Thorac Cardiovasc Surg 2010;140:174-81.
45. Taghavi S, Jayarajan SN, Komaroff E, et al. Continuous flow left ventricular assist device technology has influenced wait times and affected donor allocation in cardiac transplantation. J Thorac Cardiovasc Surg 2014;147:1966-71.
46. Donneyong M, Cheng A, Trivedi JR, et al. The association of pretransplant HeartMate II left ventricular assist device placement and heart transplantation mortality. ASAIO J 2014;60:294-9.
47. Gorodeski EZ, Chu EC, Reese JR, et al. Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure. Circ Heart Fail 2009;2:320-4.
48. Starling RC, Naka Y, Boyle AJ, et al. Results of the post-U.S. food and drug administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: A prospective study using the INTERMACS (interagency registry for mechanically assisted circulatory support). J Am Coll Cardiol 2011;57:1890-8.
49. Russo MJ, Davies RR, Sorabella RA, et al. Adult-age donors offer acceptable long-term survival to pediatric heart transplant recipients: An analysis of the united network of organ sharing database. J Thorac Cardiovasc Surg 2006;132:1208-12.
50. Blanche C, Blanche DA, Kearney B, et al. Heart transplantation in patients seventy years of age and older: A comparative analysis of outcome. J Thorac Cardiovasc Surg 2001;121:532-41.
51. Writing Group Members, Lloyd-Jones D, Adams RJ, et al. Heart disease and stroke statistics--2010 update: A report from the american heart association. Circulation 2010;121:e46-e215.
52. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003;349:931-40.